The future challenges will be to establish novel therapies to (a) specifically inhibit the NRF2 pathway in cancer cells, (b) increase NRF2 activation in specific cell types and/or brain regions, and (c) modulate NRF2 pathway in senescent cells. The gene discussed is NFE2L2; the disease is cancer.